RadNet (RDNT) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Apr, 2026Executive summary
The annual meeting is scheduled for June 2, 2026, with voting on director elections, auditor ratification, executive compensation, and an amendment to the Equity Incentive Plan.
Proxy materials are available online, and shareholders are encouraged to vote via internet, phone, or mail.
A quorum requires a majority of outstanding shares, with 78,271,515 shares issued and outstanding as of the record date.
Voting matters and shareholder proposals
Six directors are nominated for election to serve until the 2027 annual meeting.
Ratification of Ernst & Young LLP as independent auditor for 2026 is proposed.
Advisory vote on executive compensation (say-on-pay) is included, with 83% approval in 2025.
Approval sought for an amendment and restatement of the Equity Incentive Plan, increasing the share reserve by 3,000,000 shares and extending the plan to 2036.
Board of directors and corporate governance
The board consists of a mix of independent and employee directors, with a lead independent director and standing audit, compensation, and nominating/governance committees.
Directors attended all meetings except one, and the board supports director education and biannual self-assessment.
Majority voting and director resignation policies are in place for uncontested elections.
Stockholder engagement and communication channels are emphasized.
Latest events from RadNet
- Key votes on directors, auditor, executive pay, and equity plan set for June 2026 meeting.RDNT
Proxy filing20 Apr 2026 - AI-powered radiology and digital health drive double-digit growth and industry transformation.RDNT
44th Annual J.P. Morgan Healthcare Conference16 Apr 2026 - Advanced imaging, digital health, and AI drive robust growth and industry leadership into 2026.RDNT
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong growth, digital health expansion, and AI integration drive positive 2026 outlook.RDNT
Barclays 28th Annual Global Healthcare Conference12 Mar 2026 - Record revenue and EBITDA, strong Digital Health and AI growth, and robust 2026 outlook.RDNT
Q4 20256 Mar 2026 - Acquisition forms global radiology AI leader, targeting $140M ARR and rapid integration by 2026.RDNT
M&A announcement5 Mar 2026 - Advanced imaging, AI, and acquisitions drive robust growth and margin expansion for 2026.RDNT
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Acquisition of Gleamer accelerates DeepHealth's leadership in radiology AI and automation.RDNT
Investor update2 Mar 2026 - AI, joint ventures, and managed care drive growth and efficiency in a consolidating radiology sector.RDNT
Morgan Stanley 23rd Annual Global Healthcare Conference3 Feb 2026